Administrative Supplements to Support Cancer Disparity Collaborative Research
The Administrative Supplements to Support Cancer Disparity Collaborative Research Program (the Collaborative) seeks to catalyze and broaden research and collaborations across the Cancer Health Disparities (CHD) spectrum. The Collaborative supports new CHD research among investigators who do not normally conduct it and encourages the partnership of experienced cancer research investigators with CHD-focused researchers. The trans-NCI program aims to accelerate and strengthen multi-disciplinary CHD research in wide-ranging areas.
Key facts about the Collaborative:
- Proposed collaborations should focus on achieving research objectives that by necessity rely on diverse and complementary expertise, technical capabilities, and resource sets.
- Importantly, the supplemental proposal is required to be within the scope of the parent award and should expand the original aims to include a CHD component and possible inclusion of international comparator cohorts.
The Collaborative Funding Opportunity Announcement is PAR-22-114. Access the Collaborative Frequently Asked Questions.
|
Title & CRCHD Contact |
Application Due Date & Purpose |
|---|---|
|
Dr. Maria Jamela (Jay) Revilleza Dr. Sarah Szurek
|
Due Dates: September 6, 2024, January 23, 2025 The purpose of the Collaborative is to promote cancer disparities research among NCI-funded non-disparity researchers and encourage collaboration with cancer disparities-focused researchers, as well as to accelerate and strengthen multi-disciplinary cancer disparities research in wide-ranging areas.
|